Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Thoracic 2Other 2Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Pituitary Neoplasms 1Pain 1Agnosia 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anti-Inflammatory Agents, Non-Steroidal × Endocrine × Clear all
NCT04611685 2020-11-03

Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
202 enrolled
Endocrine

Agnosia, Pain, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡